THE INFORMATION CONTAINED WITHIN THIS
ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE
INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU)
NO. 596/2014, AS AMENDED ("MAR"). ON THE PUBLICATION OF THIS
ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE
("RIS"), THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE
PUBLIC DOMAIN.
DiscovOre plc
(To be renamed Oscillate plc)
AQSE: ORE
(“DiscovOre plc” or the
“Company”)
All Resolutions
passed at General Meeting, including a broadened investment policy
to include Medical Psychedelics, Change of Name & Change of
TIDM to, AQSE: MUSH
The Company is pleased to announce that at the General Meeting
of Shareholders held today, all resolutions were duly passed.
The Company’s name will change to Oscillate plc and the change
of name will be effective once Companies House has issued a
certificate of change of name (“The Certificate”). A further
announcement confirming the change of name will be made in due
course. Upon issue of the Certificate, the Company’s ordinary
shares, shall be traded on AQSE Growth Market under the ticker
“MUSH”. There will be no change to the ISIN number.
The Company’s investment strategy will be broadened to include
investment in Medical Psychedelic opportunities where consistent
with the Company’s legal opinion and will be subject to certain
review and conditions with the Company’s counsel. Upon conclusion
of today’s General Meeting, DiscovOre plc (to be renamed “Oscillate
plc”) will maintain an investment strategy covering, medical
psychedelics, medical cannabis and special situations.
The Company has also updated the corporate website/domain to
reflect the name change and broadened investment strategy,
www.oscillateplc.com
DiscovOre plc,
London, 13th July 2021
The Directors of the Company, who have
issued this RIS announcement after due and careful enquiry, accept
responsibility for its content.
Enquiries
Company:
Burns Singh Tennent-Bhohi (Director)
Conrad Windham (Director)
Direct Office Line: +44 (0) 20 3778 0755
Corporate Adviser:
Peterhouse Capital Limited
Guy Miller & Mark Anwyl
Telephone: +44 (0) 20 7220 9796
